Objective The ethiopathogenesis of irritable bowel syndrome (IBS) is unknown. While a link
to the gut microbiome is postulated, the heterogeneity of the healthy gut makes it difficult to …

Background & Aims We have limited knowledge about the association between the
composition of the intestinal microbiota and clinical features of irritable bowel syndrome …

Objective Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that is difficult
to diagnose and treat due to its inherent heterogeneity and unclear aetiology. Although there …

Objective. Breath testing and duodenal culture studies suggest that a significant proportion
of irritable bowel syndrome (IBS) patients have small intestinal bacterial overgrowth. In this …

Background and aims Irritable bowel syndrome (IBS) is a common functional gastrointestinal
disorder that may be triggered by enteric pathogens and has also been linked to alterations …

BACKGROUND & AIMS: Irritable bowel syndrome (IBS) has been associated with
disruptions to the intestinal microbiota, but studies have had limited power, coverage, and …

Background Irritable bowel syndrome (IBS) is the most prevalent functional bowel disorder,
but its pathophysiology is still unknown. Although a microbial signature associated with IBS …

Irritable bowel syndrome (IBS) is a heterogeneous condition with multifactorial
pathogenesis. We studied deeply phenotyped individuals with microbiota sequencing …

Irritable bowel syndrome (IBS) is the most common functional gastrointestinal disorder in
western countries. Previous studies on IBS, mostly based on faecal samples, suggest …

Background There is increasing evidence to support a role for the gastrointestinal microbiota
in the etiology of irritable bowel syndrome (IBS). Given the evidence of an inflammatory …